Renaissance Technologies’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-427,300
| Closed | -$14M | – | 4599 |
|
|
2022
Q2 | $14M | Buy |
427,300
+19,700
| +5% | +$623K | 0.02% | 926 |
|
|
2022
Q1 | $10.7M | Sell |
407,600
-37,466
| -8% | -$914K | 0.01% | 1079 |
|
|
2021
Q4 | $10.6M | Sell |
445,066
-46,400
| -9% | -$1.15M | 0.01% | 1039 |
|
|
2021
Q3 | $12.3M | Sell |
491,466
-32,700
| -6% | -$833K | 0.02% | 908 |
|
|
2021
Q2 | $13.6M | Sell |
524,166
-68,800
| -12% | -$1.87M | 0.02% | 975 |
|
|
2021
Q1 | $15.2M | Sell |
592,966
-232,800
| -28% | -$5.97M | 0.02% | 935 |
|
|
2020
Q4 | $16.5M | Sell |
825,766
-47,279
| -5% | -$926K | 0.02% | 850 |
|
|
2020
Q3 | $15M | Buy |
873,045
+81,228
| +10% | +$1.54M | 0.01% | 896 |
|
|
2020
Q2 | $17.3M | Buy |
791,817
+262,372
| +50% | +$6.01M | 0.01% | 905 |
|
|
2020
Q1 | $12.2M | Buy |
529,445
+170,500
| +48% | +$4.96M | 0.01% | 1040 |
|
|
2019
Q4 | $11.8M | Buy |
358,945
+120,345
| +50% | +$3.86M | 0.01% | 1340 |
|
|
2019
Q3 | $7.6M | Buy |
238,600
+76,200
| +47% | +$2.22M | 0.01% | 1566 |
|
|
2019
Q2 | $4.17M | Buy |
162,400
+108,300
| +200% | +$2.76M | ﹤0.01% | 1909 |
|
|
2019
Q1 | $1.37M | Buy |
54,100
+3,632
| +7% | +$108K | ﹤0.01% | 2518 |
|
|
2018
Q4 | $1.72M | Sell |
50,468
-43,621
| -46% | -$1.42M | ﹤0.01% | 2318 |
|
|
2018
Q3 | $3.35M | Buy |
94,089
+26,744
| +40% | +$944K | ﹤0.01% | 2028 |
|
|
2018
Q2 | $2.32M | Sell |
67,345
-98,600
| -59% | -$3.46M | ﹤0.01% | 2190 |
|
|
2018
Q1 | $5.58M | Sell |
165,945
-10,300
| -6% | -$326K | 0.01% | 1748 |
|
|
2017
Q4 | $6.73M | Buy |
+176,245
| New | +$7.04M | 0.01% | 1625 |
|
|
2017
Q3 | – | Sell |
-126,962
| Closed | -$4.74M | – | 3435 |
|
|
2017
Q2 | $4.74M | Sell |
126,962
-22,332
| -15% | -$807K | 0.01% | 1745 |
|
|
2017
Q1 | $5.86M | Buy |
149,294
+103,494
| +226% | +$3.88M | 0.01% | 1575 |
|
|
2016
Q4 | $1.59M | Buy |
45,800
+32,600
| +247% | +$1.28M | ﹤0.01% | 2334 |
|
|
2016
Q3 | $519K | Buy |
+13,200
| New | +$526K | ﹤0.01% | 2800 |
|
|
2016
Q2 | – | Sell |
-56,945
| Closed | -$2.19M | – | 3568 |
|
|
2016
Q1 | $2.19M | Sell |
56,945
-81,300
| -59% | -$3.03M | ﹤0.01% | 2167 |
|
|
2015
Q4 | $6.64M | Buy |
138,245
+111,400
| +415% | +$5.16M | 0.01% | 1269 |
|
|
2015
Q3 | $1.06M | Sell |
26,845
-60,600
| -69% | -$2.58M | ﹤0.01% | 2349 |
|
|
2015
Q2 | $3.72M | Sell |
87,445
-900
| -1% | -$35.9K | 0.01% | 1639 |
|
|
2015
Q1 | $3.49M | Buy |
+88,345
| New | +$3.26M | 0.01% | 1594 |
|
|
2014
Q4 | – | Sell |
-269,045
| Closed | -$7.94M | – | 3181 |
|
|
2014
Q3 | $7.94M | Sell |
269,045
-136,100
| -34% | -$3.76M | 0.02% | 907 |
|
|
2014
Q2 | $10.2M | Buy |
405,145
+237,200
| +141% | +$5.86M | 0.02% | 829 |
|
|
2014
Q1 | $4.33M | Sell |
167,945
-4,329
| -3% | -$109K | 0.01% | 1342 |
|
|
2013
Q4 | $3.88M | Buy |
172,274
+156,000
| +959% | +$3.01M | 0.01% | 1351 |
|
|
2013
Q3 | $231K | Buy |
+16,274
| New | +$218K | ﹤0.01% | 2532 |
|
Other funds holding NTUS
Renaissance Technologies's NTUS Position: Q3 2022 in Review
Renaissance Technologies sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 427,300 shares — an estimated $14M sold.
Renaissance Technologies first reported a position in NTUS in Q3 2013 and held it in 33 quarters. The position peaked at $17.3M in Q2 2020. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Renaissance Technologies reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Renaissance Technologies sold 427,300 Natus Medical Inc shares in Q3 2022, an estimated $14M.
- Renaissance Technologies first reported a position in Natus Medical Inc in Q3 2013 and held it in 33 quarters.
- Renaissance Technologies's Natus Medical Inc position peaked at $17.3M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.